Grant appeal rights are not one thing you either have or you don’t. They are set by a single sentence in the termination letter: the sentence naming the reason. Under 2 CFR 200.342, an agency that imposes a remedy for noncompliance must maintain written procedures and give the recipient an opportunity to object and submit information challenging the action. If the letter instead says the award no longer effectuates program goals or agency priorities, that duty thins out fast — and a pending rewrite of the same section would erase it.
The short version:
- Your grant appeal rights start with the reason line. “Noncompliance,” “failure to comply,” or “disallowed cost” opens an administrative appeal path. “Agency priorities” or “convenience” generally does not.
- Noncompliance disputes usually run two rungs: an agency-level review, then a departmental board. At HHS that means the agency first, then the Departmental Appeals Board under 45 CFR Part 16.
- The deadline is short and strict — typically 30 days from the date you receive the decision, not the date you route it to counsel.
- OMB’s proposed rewrite of 2 CFR 200.342 would limit objection and appeal rights to noncompliance terminations only, pushing everyone else to the Court of Federal Claims, which awards money but not reinstatement.
- A Senate continuing appropriations provision would block that rule until December 11, so the current text is what governs your award today.
The Reason Line Routes You, Not the Merits
Recipients read termination letters for the dollar figure and the effective date. The operative text is higher up: the paragraph stating why. Federal grants law treats terminations as two different animals depending on that stated basis, and the two get different process.
The enforcement side is spelled out in 2 CFR 200.339. When an agency or pass-through entity determines that noncompliance cannot be fixed with specific conditions, it may withhold payments, disallow costs, suspend or terminate the award in whole or in part, start suspension or debarment proceedings, or pursue other legally available remedies. Every one of those is a remedy for noncompliance — and every one of them triggers the objection duty in 200.342.
The other basis is discretionary. Current 200.340(a)(4) permits termination when an award “no longer effectuates the program goals or agency priorities.” That clause was added at the end of the first Trump administration and, as Greenberg Traurig’s analysis of the proposed rewrite notes, went essentially unused until recently. It carries no finding against you. That is exactly why it carries less process: there is no compliance determination for you to rebut.
So the practical first move on receipt is not to draft a response. It is to classify the letter. Grantees managing federal grant awards should keep the reason line, the citation to 200.340, and the appeal-rights paragraph in a single file the day the notice lands.
Where Grant Appeal Rights Actually Come From
Section 200.342 does not itself create a tribunal. It requires each agency to maintain written procedures for objections, hearings, and appeals, and to honor whatever hearing or appeal entitlements exist under any statute or regulation applicable to the action. The actual forum lives in program-specific rules, and those vary more than most recipients expect.
Public Health Service agencies are the clearest example. The NIH Grants Policy Statement lays out a first-level appeal that must be exhausted before the Departmental Appeals Board will take the case. NIH assumes jurisdiction over four categories under 42 CFR 50.404: termination for failure to carry out the approved project or comply with award terms; a determination that an expenditure was unallowable or that the recipient failed to account for funds; denial of a non-competing continuation for failure to comply with a prior award; and a determination that a grant is void. The request for review is due no later than 30 days after written notification of the adverse determination, extendable only for good cause.
USDA’s National Institute of Food and Agriculture runs a different sequence entirely. Under 7 CFR 3430.59, NIFA must issue written notice of intent to disallow a cost with the factual and legal basis stated; the awardee gets 60 days to respond with evidence and argument, plus a possible 30-day extension requested before the original window closes; NIFA then has 60 days to issue a management decision. Only after a demand for payment does a further 60-day review request become available.
Thirty days at NIH. Sixty at NIFA. Same statute-level framework, different clocks. There is no government-wide appeal calendar, which is why the appeal-rights paragraph in your specific notice is the only schedule that matters.
The Departmental Board Rung, and How Recipients Lose It
Once the agency issues its final written decision, HHS recipients move to the Departmental Appeals Board. The Board’s own Appellate Division practice manual is blunt about how appeals die. Three conditions must be met: the program must use the Board for dispute resolution, the appellant must have received a final written decision and appealed within 30 days of receiving it, and any preliminary appeal process required by regulation must be exhausted first.
Two details in that manual do most of the damage. First, the 30 days run from receipt by the appellant “or any of its agents” — so time spent circulating the letter internally or forwarding it to outside counsel counts against you. Second, the Board applies the deadline strictly. Administrative mistakes and internal inefficiency are not accepted as good reason for waiver, and the Board notes it has rejected many appeals for late filing while only rarely accepting a late one.
The notice of appeal itself is short: a copy of the final decision, a statement of the amount in dispute, and a brief statement of why the decision is wrong. The heavy lifting comes next, on a 30-day cycle for the appellant’s brief and appeal file, 30 days for the respondent, and 15 days for a reply. Disputes of $25,000 or less run on an expedited track with simultaneous filings.
If your notice is ambiguous about whether it is the final decision, the manual’s advice is to file anyway and protect the date. A premature appeal can be sorted out. A late one usually cannot.
What the Proposed Rewrite Would Take Off the Table
OMB published “Regulation for Federal Financial Assistance” in the Federal Register on May 29, 2026, docketed as OMB-2026-0034, with the comment period closing July 13. It would convert the government-wide grants framework from guidance into binding regulation — the largest revision since the Uniform Guidance was issued in 2013.
For grant appeal rights, the change is narrow on paper and large in effect. Proposed 200.342 would limit objection, hearing, and appeal rights to terminations for noncompliance. For discretionary terminations and suspensions, agencies would owe no administrative review at all. A recipient wanting to challenge one would have to go to the U.S. Court of Federal Claims, which can award money damages but not injunctive relief. OMB characterizes this as a minor clarifying revision; in practice it converts the reason line from a routing signal into a switch that can turn the administrative path off completely.
The judicial backdrop points the same direction. Following the Supreme Court’s orders in the NIH and California cases, most courts have held that arbitrary-and-capricious challenges to grant terminations belong in the Court of Federal Claims under the Tucker Act rather than district court, though constitutional claims have continued to proceed in district court and the Ninth Circuit’s March 2026 decision in Pacito v. Trump held that certain cooperative agreements are not “contracts” for Tucker Act purposes.
Timing is unsettled. OMB has signaled an intent to finalize by October 1, 2026. A continuing appropriations bill released by the Senate Appropriations Committee would bar OMB from finalizing the rewrite until December 11, 2026, and would suspend any version finalized before enactment. That package still has to pass both chambers. We track the moving pieces on the OpenGrants industry news feed.
Build the Record Before the Letter, Not After
Appeals are decided on a file. By the time a final decision arrives, the file is largely fixed — you are arguing from documents that already exist, on a 30-day clock, against an agency that has had months.
Three habits change the odds, and none of them require a lawyer on retainer.
Answer every intermediate notice in writing. Specific conditions under 200.208, a corrective action plan, a monitoring finding, an audit question — each one is a chance to put your version into the administrative record while it is cheap. Silence gets read as concession later.
Keep contemporaneous performance evidence, not reconstructed evidence. Progress against the approved scope, board minutes approving budget shifts, prior-approval requests and the responses, emails with the grants management officer. A reimbursement claim assembled after termination looks like advocacy; a monthly file looks like fact.
Log receipt dates. Date-stamp every adverse notice on arrival and calendar the deadline that day, counting from receipt. Under the Board’s rules the count includes weekends and holidays, rolling only if the due date lands on a Saturday, Sunday, or federal holiday. Nonprofit recipients with volunteer-heavy administration lose more appeals to mail handling than to the merits.
Frequently Asked Questions
Can I appeal a rejected grant application?
Generally no. The appeal frameworks in 2 CFR 200.342 and 45 CFR Part 16 cover post-award adverse determinations — terminations, disallowed costs, denied continuations, voided awards. A competitive merit-review loss is not an adverse determination against you, and most agencies offer only a debriefing or summary statement. Read the scores instead and reuse them on the next cycle.
Do subrecipients get the same appeal rights?
Not automatically. Section 200.339 lets a pass-through entity impose remedies on a subrecipient, and 200.342 obligates the pass-through to honor hearing and appeal entitlements that apply to the action. But the primary dispute forum for a subrecipient is usually the pass-through’s own written procedures, not the federal agency’s board. Ask for those procedures before you sign the subaward.
Does filing an appeal stop the money from stopping?
Usually not. An appeal contests the decision; it does not automatically stay withheld payments or restore terminated funding. That distinction is what makes the Court of Federal Claims routing consequential — that court awards money damages, not reinstatement, so an organization that needs the program to keep running may have no forum that can order it.
What is the deadline to appeal a federal grant termination?
It depends on the agency. HHS and NIH recipients generally have 30 days from receipt of the written determination, with an agency-level review required before the Departmental Appeals Board. USDA NIFA gives 60 days to respond to a notice of intent to disallow, extendable by 30 days on a timely request. The controlling deadline is the one printed in your notice.
Should I hire counsel for a grant appeal?
For disputes at or under $25,000, the expedited Board process is designed to be navigable in-house. Above that, or where suspension and debarment is on the table, counsel earns its fee. Either way, file the notice of appeal first to protect the date, then decide on representation.
Bottom Line
Grant appeal rights are not something you invoke on demand — they are something the reason line hands you or withholds. That line in a termination letter is not boilerplate. It is the routing instruction that determines whether you get an agency review and a departmental board, or a lawsuit in a court that cannot give your program back. Under the current rule that split already exists; under the proposed rewrite it hardens into text.
The concrete action this week is small and unglamorous: pull the general terms and conditions for each active federal award, find the section that states the objection and appeal procedure, and record the forum and the day count in the same tracker where you keep report deadlines. Most recipients cannot name that forum for their largest award. That is the gap worth closing before any letter arrives, and it applies equally to small business award holders and large institutional recipients.
If you are rebuilding award administration to survive this cycle — documentation, prior approvals, an audit-ready file — the OpenGrants grant writing and management team can help you set up the record before you need it, and our funding database can help you build the diversified pipeline that makes a single adverse determination survivable.

